180 Life Sciences (ATNF) Competitors $1.86 -0.08 (-4.12%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ATNF vs. NLSP, EYEN, EVOK, ADIL, GRI, TRIB, GLTO, ABVC, MBRX, and VINCShould you be buying 180 Life Sciences stock or one of its competitors? The main competitors of 180 Life Sciences include NLS Pharmaceutics (NLSP), Eyenovia (EYEN), Evoke Pharma (EVOK), Adial Pharmaceuticals (ADIL), GRI Bio (GRI), Trinity Biotech (TRIB), Galecto (GLTO), ABVC BioPharma (ABVC), Moleculin Biotech (MBRX), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical products" industry. 180 Life Sciences vs. NLS Pharmaceutics Eyenovia Evoke Pharma Adial Pharmaceuticals GRI Bio Trinity Biotech Galecto ABVC BioPharma Moleculin Biotech Vincerx Pharma NLS Pharmaceutics (NASDAQ:NLSP) and 180 Life Sciences (NASDAQ:ATNF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, community ranking, profitability, dividends, earnings and media sentiment. Does the MarketBeat Community believe in NLSP or ATNF? NLS Pharmaceutics received 6 more outperform votes than 180 Life Sciences when rated by MarketBeat users. However, 66.67% of users gave 180 Life Sciences an outperform vote while only 57.14% of users gave NLS Pharmaceutics an outperform vote. CompanyUnderperformOutperformNLS PharmaceuticsOutperform Votes857.14% Underperform Votes642.86% 180 Life SciencesOutperform Votes266.67% Underperform Votes133.33% Which has more volatility and risk, NLSP or ATNF? NLS Pharmaceutics has a beta of -0.52, indicating that its stock price is 152% less volatile than the S&P 500. Comparatively, 180 Life Sciences has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500. Which has stronger earnings and valuation, NLSP or ATNF? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNLS PharmaceuticsN/AN/A-$12.17MN/AN/A180 Life SciencesN/AN/A-$19.93MN/AN/A Do institutionals & insiders hold more shares of NLSP or ATNF? 4.1% of 180 Life Sciences shares are held by institutional investors. 16.4% of NLS Pharmaceutics shares are held by insiders. Comparatively, 0.2% of 180 Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to NLSP or ATNF? In the previous week, NLS Pharmaceutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for NLS Pharmaceutics and 1 mentions for 180 Life Sciences. NLS Pharmaceutics' average media sentiment score of 0.21 beat 180 Life Sciences' score of 0.00 indicating that NLS Pharmaceutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NLS Pharmaceutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 180 Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is NLSP or ATNF more profitable? NLS Pharmaceutics' return on equity of 0.00% beat 180 Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets NLS PharmaceuticsN/A N/A N/A 180 Life Sciences N/A -558.93%-54.10% SummaryNLS Pharmaceutics beats 180 Life Sciences on 7 of the 10 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATNF vs. The Competition Export to ExcelMetric180 Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.91M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E RatioN/A10.5990.0517.20Price / SalesN/A196.061,117.09117.04Price / CashN/A57.1643.1037.85Price / Book-7.755.094.784.78Net Income-$19.93M$151.83M$120.31M$225.60M7 Day Performance-3.63%-2.14%-1.92%-1.23%1 Month Performance-17.33%-4.56%13.65%0.46%1 Year Performance-47.40%8.87%28.34%15.24% 180 Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATNF180 Life SciencesN/A$1.86-4.1%N/A-43.3%$1.91MN/A0.007News CoverageGap UpNLSPNLS Pharmaceutics0.364 of 5 stars$1.94+1.6%N/A+336.9%$7.40MN/A0.006News CoverageGap UpEYENEyenovia1.4856 of 5 stars$0.08-2.3%$2.00+2,351.0%-94.9%$7.05M$31,832.00-0.1140Gap DownHigh Trading VolumeEVOKEvoke Pharma0.0363 of 5 stars$4.71flatN/A-63.3%$7.02M$5.18M-0.434News CoverageADILAdial Pharmaceuticals3.3523 of 5 stars$1.09flat$8.00+633.9%-41.8%$6.98MN/A0.0020News CoveragePositive NewsGRIGRI Bio2.5218 of 5 stars0.77-3.8%N/A-97.8%$6.88MN/A0.001TRIBTrinity Biotech1.2132 of 5 stars$0.88-2.8%N/A-64.5%$6.71M$56.83M-0.39480News CoveragePositive NewsGap DownGLTOGalecto2.1615 of 5 stars$5.05-0.6%$10.00+98.0%-70.2%$6.65MN/A-0.2740ABVCABVC BioPharma0.9744 of 5 stars$0.51+0.5%N/A-52.4%$6.59M$509,788.00-0.5830News CoverageMBRXMoleculin Biotech2.3585 of 5 stars$2.17-6.5%$24.00+1,006.0%-83.4%$6.51MN/A0.0020News CoverageVINCVincerx Pharma2.2589 of 5 stars$0.19-2.1%$2.00+969.5%-75.1%$6.29MN/A-0.1960Gap Up Related Companies and Tools Related Companies NLSP Competitors EYEN Competitors EVOK Competitors ADIL Competitors GRI Competitors TRIB Competitors GLTO Competitors ABVC Competitors MBRX Competitors VINC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ATNF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATNF Stock Alerts